EADV 2023 Day 3 Evening: Abrocitinib for Prurigo Nodularis in Chronic Pruritis

Jeremy Visser
Oct 14, 2023
1 min read

Dr. Fiona Lovegrove reports live from the 2023 EADV Congress in Berlin and discusses the late breaking presentation on the efficacy and safety of abrocitinib for prurigo nodularis in chronic pruritis.

Recent Posts

See All

VIDEO: Acne patients trust dermatologists despite high prevalence of social media skinfluencers

Canadian dermatology residents express views on inclusion, diversity, and equity in 3rd annual national essay competition

The Chronicle of Skin & Allergy, in partnership with the Dermatology Industry Taskforce on Inclusion, Diversity and Equity (DiTiDE), is...

VIDEO: Psoriasis associated with excessive sun exposure behaviours

it's where dermatology lives

EADV 2023 Day 3 Evening: Abrocitinib for Prurigo Nodularis in Chronic Pruritis

Recent Posts

Comments